Clinical Application of Carbon Nanoparticles in Lymph Node Tracing and Surgery Guiding of Colorectal Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06783985

Acronym

CNP-CRC

Enrollment

146

Registered

2025-01-20

Start date

2022-03-16

Completion date

2024-04-20

Last updated

2025-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

carbon nanoparticle, colorectal cancer, lymph node

Brief summary

This trial aims to clarify the relationship between carbon nanoparticles labeled lymph nodes and lymph node metastasis in different lymph node regions of colorectal cancer, and to clarify the application value of carbon nanoparticles in lymph node dissection in colorectal cancer surgery.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. a diagnosis of colorectal cancer; 2. endoscopic injection of CNP suspension preoperatively 3. planned radical resection of colorectal cancer 4. older than 18 years of age

Exclusion criteria

(a) emergency surgery;

Design outcomes

Primary

Measure	Time frame
The relationship between carbon nanoparticle stained lymph nodes and metastatic lymph nodes	From enrollment to the pathology report at 2 weeks

Secondary

Measure	Time frame
Carbon nanoparticle stained lymph nodes from different lymph node groups.	From enrollment to the pathology report at 2 weeks

Countries

China

Outcome results